More on Myriad Genetics (MYGN +8.9%): The mixed ruling was not a surprise to many, as the Court...

|About: Myriad Genetics, Inc. (MYGN)|By:, SA News Editor

More on Myriad Genetics (MYGN +8.9%): The mixed ruling was not a surprise to many, as the Court expressed skepticism over whether human DNA extracted from the body could be patented like a mechanical invention during arguments in April. Nevertheless, it removes an overhang for the sector. Read more here: (Supreme Court Ruling).